FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease The Medical News, 03 Aug 2017 The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib…